of clinical trials suffer operational delays
Directly due to patient and sites enrollment struggles.
SourcePremier Research · Enhancing MedTech Patient Enrollment: the value of a recruitment lead, April 2024
Biopharma & Life Sciences
Build a patient-centric AI ecosystem to accelerate your pipeline and own your transformation.




Industry context
of clinical trials suffer operational delays
Directly due to patient and sites enrollment struggles.
SourcePremier Research · Enhancing MedTech Patient Enrollment: the value of a recruitment lead, April 2024
reduction in drug development time targeted by the industry by 2030
A time reduction targeted by the industry, considering AI potential.
of R&D costs are related to clinical operations
Taking over on discovery as the priority expense center.
SourceNational Library of Medicine · Drug Development, September 2024
to be unlocked from the 2025–2030 patent cliff
A time-boxed market opportunity across the whole industry.
NDA data generated per drug submission
To store and share, avoiding corporate silos.
SourceFDA · Electronic Submissions Gateway, submit using eCTD
US regulations, rules, or guidance
To study, and comply with.
of new drugs are dedicated to precision medicines
To test with micro-populations through complex care pathways — an even more accelerated and further fragmented commercial model.
of health-related queries show AI overviews
AI chatbots are already part of patients’ pathways.
SourceGoogle AI Overviews Impact on Healthcare Traffic: What the Data Shows, February 2026
have adopted AI in at least one isolated workflow
Pharma is using its potential.
SourceIntuition Labs · AI Adoption in Pharma & Biotech, June 2026
of pharma AI pilots never reach production
But scaling remains elusive: secured, trustable, auditable, repeatable processes are complex to set-up.
SourceIntuition Labs · Pharma AI Pilots: Fixing Data Foundations for Scale, March 2026
Our vision
Our offer
We deliver production-grade agents, deployed in weeks to start and accelerate your AI journey. We pair deep pharma domain knowledge with execution to guarantee traceability and ROI.
Build secure, medically trained agentic platforms connecting patients, sites and pharma.
Tangible value
Use cases
Deploy AI agents as digital coworkers to execute end-to-end clinical and safety workflows.
Tangible value
Use cases
Establish compliant data foundations and commercial tools that maximize marketing ROI, and make inspection and audit readiness routine.
Tangible value
Use cases
Global pharma · PharmacovigilanceA full signal dossier, done in minutes instead of weeks
Dynamic safety-signal analysis for a given molecule, integrating internal safety data, publications and real-world evidence with MedDRA, and generating an auditable dossier for protocol design and compliance.
View case study →
Pharma & biotech sponsors · Clinical developmentSponsor onboarding to live trial
A patient-first web space where individuals self-identify for clinical research: AI turns the study protocol into plain-language questionnaires, pre-screens eligibility and routes qualified volunteers straight to authorized trial coordinators. GDPR and HIPAA compliant.
View case study →
Pharma IT quality & manufacturingRisk-based audit to remediation roadmap
A risk-based audit of data flows, audit trails and access rights against 21 CFR Part 11, EU Annex 11 and GAMP 5, scored across six GxP dimensions, with a CAPA tracker and a prioritized remediation roadmap.
View case study →
Global life-sciences group · Medical affairsHow answer engines cite your molecule, its indications and your patient information, market by market: a Generative Engine Optimization audit that flags inaccurate LLM answers and sets out compliant corrective action for Medical Affairs, Marketing & Compliance.
View case study →
Top-10 global pharma · Patient & HCP engagementMedically trained voice & chat
A medically trained agent answering patient and HCP questions on medical information, treatments and dosing, grounded strictly in approved documentation, with MedDRA-coded adverse-event triage and clean escalation to medical teams. GxP-ready and FDA 21 CFR Part 11 compliant.
View case study →Pharmacovigilance, clinical development, medical affairs, GEO — and every other sector we work in.
Browse all →